Reddit Posts
16 stocks ready for a Stock Short Squeeze (Buy Ideas) 2021 $CELH $DMTK $TMDX several more Short interest on the charts, days to cover #stock #Ideas
16 stocks ready for a Stock Short Squeeze (Buy Ideas) 2021 $CELH $DMTK $TMDX several more Short interest on the charts, days to cover #stock #Ideas
TMDX receives approval from FDA Advisory Panel.
Mentions
According to this… TMDX has 110% of institutional ownership according to IBKR https://preview.redd.it/3wpixf47uowg1.jpeg?width=1290&format=pjpg&auto=webp&s=53c5af38f9271a99dc2962693680ce312b90f3bf
TMDX sounds awesome, I strongly considered a position. Did you see the short report accusing them of black market organ trafficking though lol. Decided to pass but I could end up regretting it.
TMDX -- just look at earnings. warm perfusion for transplanted organs. It's changing the game and they are about to go global. No competition. They keep beating earnings. Also, I have worked with this technology and can attest to it being the future. It's changing the game for transplant for sure.
Bought RDDT GOOG META TMDX
TMDX- super cool company that saves lives. Go down a lot during this sell off but fundamentally nothing has changed. They’re growing fast and continuing to expand. CRDO- also down a lot but they’re growing extremely fast and demand is still there. Wouldn’t say this one is as under the radar. RBRK- would argue this is the best name to add in cybersecurity right now but DYOR
TMDX has been going down because of concerns over rising fuel costs. It seems like they’re able to pass those costs down to customers and margins get impacted minimally. Great opportunity to buy (especially if it goes below 120)
What 2 leaps would print the most out of GOOG, RDDT, CRDO, and TMDX?
TMDX - I have previously posted why this is such gold and was called ‘AI Slop’. I’m okay with that accusation because highly regarded people are allowed to be afraid of proper grammar. Anyways, this is gonna pump for a while. In at 130, getting out at 165
I never bought into TMDX and wish I would have. The shift to logistics just makes this awesome company that much cooler.
TMDX just popped on latest earnings — I invite you all to evaluate this company. The product is basically a circulatory system for organs procured for transplant. That may not seem important but what that does is GREATLY increase the time one has to move and transplant an organ, thereby vastly increasing the availability and viability of already scarce organs. They just got an Investigational Device Excemption for hearts, which will add on to their already FDA approved devices for Lung and Liver. And they have best earnings four quarters in a row. They just expanded their office space. Why I think this is a very good long term play is: 1) the diseases served by transplant are from diseases of vice (smoking, drinking, uncontrolled diabetes), which will never truly be conquered non-surgically because treatment requires patient compliance. 2) immunomodulating therapies are moving closer and closer to safely creating universal organs. We are years away but the point is this is revolutionary science and I believe transplanting organs for longevity is going to be a very real thing in 20 years. Fair warning: I’m a retard MD and we notoriously make bad investment decisions. This one has been paying off well. This isn’t financial advice, just something that’s actually in use that is showing up in more and more hospitals.
I’m surprised TMDX doesn’t get talked about much here. They’ve been killing it lately and I see a lot of bullish X threads
I had 4 companies reporting earnings after the bell and early returns are positive for all 4. TREX up 3%, TMDX up 9%, AXON up 15%, and MELI up 2%.
medical tech. $GH, $DXCM, $INSP, $TMDX
Everyone's forgetting the next step in the current cyberpunk dystopia buildout: Repo! The Genetic Opera, but with lower credit rates. Calls on TMDX
When I’m losing conviction it’s either time to get out or rethink strategy if it’s still correct and if so push through. That’s why I am relocating some of my capital to biotech: $IBRX, $TMDX, $ABCL and $OPEN. Each a unique moat: from solving cancer without chemo, Tesla algorithm applied to organ transplant market, palentir for biotech and a market-maker/insurance company for the housing market run by one of the best upcoming CEOs in the world. You can find it on my X @BigShort24
Anyone interested in TMDX should read the JPM healthcare conference notes. Lots of bullish news
TMDX is my best pick. Need to wait till end of 2026 tough.
TMDX is my best pick. Need to wait till end of year though
GRAB, MELI, AXON, TMDX and DUOL have been my buys going into year end. I think they could all of a very solid 2026 and beyond. They’ve all had a pretty decent selloff recently and all dominant the industry they operate in.
Some pockets of the market I have terrible luck with, like biotech and medical device. I just avoid the industries all together. UFPT is still an interesting play.. TMDX is high risk/high reward, but doesn't look crazy at these levels. Yeah the GLP1s make me not want to invest in anything related to diabetes, since just most people have Type 2. I've owned LMAT in the past, doesn't really do much lol.
ELMD Small device maker. Really small market cap, but has a clean balance sheet. 5 Quarters of double digit revenue growth, with pretty high gross margins (around 78%) Solid EPS growth and ROIC. Good insider ownership at like 21% and extremely small float of 6.55M shares available. MCK Started looking into this one a bit. Don't really know much at this point, but actually pretty low float for such a big company. Really is more of a value play at this point, since the forward PE and PEG is pretty decent for the company. However, pretty big red flag with how much insiders have been selling recently. TMDX Probably enough you can find online about them, just find them pretty interesting at these levels. Valuation doesn't look too terrible.
This has to be a bot post. I cam over this and similiar posts about the TMDX in a matter of minutes. The P/E ratio is just too dangerous. Their competitors with XVIVO and even OrganOx just offer better solutions.
#TLDR --- Ticker: TMDX Direction: Up Prognosis: Buy calls on the organ-in-a-box company. Thesis: Transporting organs in high-tech warm boxes instead of beer coolers from 1985 is printing money. They're profitable, smashing revenue growth, and insiders are buying. Risk: Valuation is high, and one bad FDA ruling or a botched quarter could nuke the stock.
TMDX although my position is full since I began buying in early 2021 so I now add opportunistically only.
TMDX has been on a crazy run this week
TMDX is such an interesting company. No position, but have been eyeing them.
META, MELI, TMDX, FOUR - all great buys today. Uber looks good too
TMDX is a great company but it swings like crazy lol. Hard not to be bullish after last earnings call and the CEO has been buying at these levels.
Long-term TMDX holder here. It has so much potential to disrupt the organ donation system. It's one of my highest conviction holdings.
Nice day for TMDX. Still find this company pretty interesting at these levels. Wonder if DUOL become a buy at some point as well.
To each their own. I've gone through drawdowns of 55%, 74%, 30%, 62%, and 68% since I first invested in TMDX. Never once did I care about the price decline because in the short-term, it's irrelevant. What matters is the underlying business. If a stock I own drops 30%, or 50%, or 70%, I view that as a welcome opportunity to add more shares if the underlying business is still executing. And it has paid off with my 5 additional purchases of TMDX shares. I understand what you're saying but I disagree entirely with the premise. A 30% drop in a growth stock is absolutely slight to me since it's an expected outcome of owning growth stocks.
My neighbor is actually a driver for transplants. I don't think they work for TMDX. It's something I want to dig more into, I know it was a popular name here for a bit. Valuation looks pretty solid to me, so it's starting to peak my interest.
Anyone here still follow or own TMDX? Valuation is starting to look really solid at these levels. I know there is some people who have posted about them in the past, wondering if anyone follows the company or owns it, has any insight! Thanks
A couple strange post-earnings flips. CROX was up 8% PM on earnings but is down 1.4% now. Meanwhile TMDX was down 7% PM on earnings but is up .7% now.
Relative unknown TMDX gonna most likely gonna have record ER!!
i love a good short squeeze, i played TMDX from 60 to 150, TREE from 60 to 300 and TNDM from 3 to 60. the thing is, in all those scenarios, i held longer than a year because the businesses were solid and i could feel comfortable BYND already ran up 4x from my cost basis but the business is still not great so i'm happy with my gains
Not a dip but GLXY, LULU, and TMDX
Yeah, the S&P’s basically an AI ETF now, if NVIDIA sneezes, the market catches a cold. I’ve been looking outside that bubble: small/mid-caps like SMCI, CELH, TMDX, or PLTR still have upside. For international exposure, TSM, JD, or NVS look solid. Metals like AEM or PAAS hedge the chaos. Feels like a good time to diversify instead of going all-in on the AI hype. But still AI is here to stay and in my turn I ll stay in AI.🤖
I followed the service provided by Jonah Lupton and made good money on his picks over the past 2 years: TMDX, ASPN, FOUR, APP, NBIS, CELH etc.
Agreed. My post was just to get an opinion on the stock. I actually just handled a 20% drop on my TMDX full port play (check my reddit post history) last month and sold for a gain today. I can digest 80-90% losses too when the Risk reward is favorable
AMD and TMDX have this cool trick where if the stock is up pre market they open the day up 5-10% and somehow crash to -10% in less than 10 seconds and never go back up, so no matter what you are always selling calls that are down a lot intraday
you can find similar trading patterns with every stock. from my experience, they work until they don't and a new pattern emerges or just devolves into complete randomness. two stocks that i've been long on, TMDX and GH, have had very predicable trading patterns on open for about a month each where they would gap up and then violently gap back down within the first 30 minutes. then suddenly, this pattern just stopped working there's no discernable reason as to why
TMDX calls are starting to look enticing, but I think it may dump all the way down to low 90s. might not tho so I did get a couple 115C just in case
Overall, in my retirement portfolio: * MELI (9.65%) * QQQ (9.57%) * VOO (9.45%) Ex. broad-market ETFs * MELI (9.65%) * SHOP (4.88%) * SOFI (3.12%) Taxable portfolio, where I only have 6 companies and 3 broad-market ETFs * TMDX (23.14%) * ATZ.TO (18.35%) * SNOW (12.50%)
Yeah Most were really good plays, didnt buy/ own every Stock on this List though, had a pretty good Return with my picks (Sofi, Hims, RKLB, ASTS, Nebius, TMDX) My conviction for those stocks is really great, I will hold them longterm, if nothing changes fundamentally.
you're choosing the wrong healthcare stocks! medical tech is where it's at medtech is carrying my portfolio - TMDX, GH, ISRG, PODD, etc
NVDA, TMDX, FCX all this year
TMDX heart trials approved! Back to the bullish grind up!
I’m buying PRCT PRCT will be a solid gain after earnings From the guy who brought you TMDX calls in their only down quarter the past 2 years, this regard is bringing PRCT. Minutes of research on Facebook leads me to believe PRCT will do well after earnings The selloff on PRCT is way overdone. The CEO is retiring, not getting fired, and he is sticking around in a consulting role. The business just posted a huge quarter—$79.2M in Q2 rev, up 48% YoY and above consensus. This is not a broken story. It is still a high-growth company that is executing. People are reacting to the headline without looking at the fundamentals. New CEO has a solid track record from Edwards Lifesciences. This is a clean baton pass, not chaos. Market sold the news, but the numbers are telling a different story. Setup looks great into earnings now that the retirement drama is out of the way.
2/2 for ER so far. TMDX amazing as always, by far my largest position. Probly over leveraged on them honestly. CLMB- medium position, what a killer report. The rest of my medium and large positions report through 8/5,6,7,8
YOLO. It takes 8 days for shorts to cover TMDX with 20% of the float short. Stock is up almost 20% pre market. This will run way higher. You’re welcome for the tip!
Haven't read the conference call transcript yet but TMDX went from mostly flat just after earnings to up 11% AH yesterday. It's now up 15% PM. I'm guessing management sounded extremely confident and relayed some very positive news on the call.
TMDX with a good but not great and not bad quarter. Management consistently sandbags guidance which allows them to raise each quarter. Came into the year expecting $541MM at the midpoint, which was increased to $575MM after Q1, and has just been increased to $595MM. More importantly, they continue to maintain profitability even as they build out their network. AH price is barely moving which is quite rare action for this company after an earnings release.
TYL and TMDX reporting shortly. The former is on my watchlist and the latter is my largest taxable position.
TMDX has earning come out after hours today, the street has undervalued their projections because they are not tracking the flights that are delivering organs translating into sales. Could be a very large beat as well as be a great short squeeze at 40% of floats that could destroy shorts. Not sure if this is the correct platform to try and get this out to but wanted someone smarter than myself to take a look. Thank you for you time
put a significant port of your money into GH i posted about TNDM other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays [https://gyazo.com/9e31bfdf1caa5be69b13fa315cd9b423](https://gyazo.com/9e31bfdf1caa5be69b13fa315cd9b423) my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process
put a significant port of your money into GH i posted about TNDM other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays [https://imgur.com/a/uQ29jep](https://imgur.com/a/uQ29jep) my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process
TMDX. It seems a lot of the big investors dont truly grasp this company even if they like it and invest it—at least based on the questions they ask at earnings calls. But at its core, it’s an organ preservation device company. Last few years they have expanded into not just providing the devices, but also the organ procurement logistics—their own pilots, planes, surgeons, other staff—making it easier and cheaper for hospitals since they don’t have pay to charter a private plane (if NORA’s own planes aren’t available) and send their own staff. I think most of their preservation devices will stick around. And they’re always trying some new variation of each one. What will definitely stick around is their procurement logistics.
this sub is so boring these days, basically bogleheads v2 put a significant port of your money into GH i posted about TNDM other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process https://imgur.com/a/uQ29jep
this sub is so boring these days, basically bogleheads v2 put a significant port of your money into GH i posted about TNDM in wsb and other subreddits when it was $4 in 2017 and told everyone to hold into a price target of $60. it reached $120. i 30xed my net worth on that one play and have since then consistently outperformed the market by investing solely in confident medtech plays (DXCM, ALGN, ABMD, ISRG, PEN) etc my most recent play i posted about on reddit was TMDX at 60 and it short squeezed all the way to $150 on stellar earnings. happy to provide proof if you want. i have an edge because i used to work for a hedge fund so i know how to build a thesis and act on it. my next double bagger is GH, PT of $100 within a year, could 4x within 3 years. they will have a near monopoly in cancer screening 5 years from now enjoy it if you trust the process
$TMDX Wednesday after market closes, bullish.
RKLB ACHR TMDX just nuke city
Either going to be a genius and be rewarded with Decius Olive Garden dinners for life or nuke my port during an aggressive bull rally buying the OSCR, TMDX, and UNH dips
RKLB, RDDT, SEA, NBIS, TSSI, TMDX, TEM, RBRK, IDN. I own all of these.
OSCR and TMDX are tag teaming my portfolio the past 2 weeks
TMDX and OSCR getting fucking crushed
ASTS PLTR TSLA TMDX JMIA I only have 6 positions with high risk. I bought Palantir more than a year ago.
> How many things have you bought that ripped, then dipped - and you missed your sell window? CRCL was a small holding - was going to invest in a small position, research further and consider whether to add more but was fine with the gain that I had in less than a week. Perhaps had I investigated further I would have owned it longer lol. oh well. Four notable instances in recent years that come to mind that were held over a longer period where I did well, should have sold and didn't (didn't *initially* appreciate the change in fundamentals/magnitude of the change, etc.) TMDX, ENPH, CELH and ELF. Still own some TMDX with a very low cost basis but wish I would have sold entirely when it neared 200. ENPH did okay but could certainly have done a lot better. Round tripped on CELH and traded it a couple of times since. ELF was another name where I did well but could have done better. I avoided a further decline in ELF the level of which that I couldn't have expected but I also missed the bottom in that because I did look at it in April and decided on something else instead but should have - given the level it got to - added that. There's definitely a number of retail/consumer tariff-impacted names that got to levels in April where I should have bought from a sheer trade standpoint even if I didn't like the businesses that much. It happens. I absolutely make mistakes, but I try to get ahead of single name issues quickly and learn from mistakes whether it be not selling when I should have better appreciated change in fundamentals or missing out on things that I did actually look at and should have considered and didn't for whatever reason (didn't like investing in the consumer, tried again with CELH/ELF, very mixed experience and thought I'll go back to not investing in retail/cpg and maybe that kept me from giving more consideration to retail that was overly obliterated in April.)
Everything isn’t overvalued, like another comment showed 8 companies near 5 or 10 year lows (valuation wise). At least 5 of those are actually good companies too. The reason people think everything is overvalued is feelings, they get fomo when a company is popular and pumps but when something “bad” comes up and it drops 40% everyone thinks “omg this company is dead and never coming back”. People should think “is that actually bad for the company long term” if not then the company is now cheap and a good buy. A good example is 2020 crash, 2022 crash, and the Trump crash which had some realllyyyyy good companies down 50%+ and people just kept saying it’s the end of the world. Well I gobbled those mfers up and each time they recovered in like 2-3 months. I got SPOT in 2022 after it dropped 50-70% up 950% on my lowest cost basis (only 750% on the first buy, but proves I doubled down after it dropped more). But at the time it analysts were saying 100% chance of recession and Spotify spent too much on Joe Rogan and people would cancel their subscription- d all this negative news, but all I saw was “70% of revenue comes from subscription when it’s only 30% of listeners” “subscriptions growing double digit members and they’re raising prices” “getting better ad revenue off free users” “cutting costs but still trying to find new growth areas like audio books and podcasts”. Another example is I bought TMDX in like Nov/dec after they got cut in half bc they bought planes to help their whole process but planes cost a lot. Well I was thinking “hey this does kinda hurt short term, but seems bullish long term”. My cost basis was $69 and it’s currently $128. I have many other examples (even bad picks for sure) but the point is all stocks aren’t overvalued but the cheap ones are usually overlooked
Been in with TMDX since May 2021 when it was under $25 per share. It's done quite well in 4 years.
TMDX- medical field, organ transplant-- the growth is going to be 10fold in five years. They are at 22 airplanes and ~3500 operations this year. They have proprietary equipment and are revolutionizing/transforming the way organs are transported. Their plan is to be doing 10,000 operations in the next five years. -Medical field is recession proof. This company's stock will be over $200 in the next year.
OSCR, ASTS, ACHR, TMDX. Just need Anduril and Data Bricks to IPO and baby you’ve got a stew going.
Gotta love when they double down. Didnt work too well for Scorpion with TMDX
Bought TMDX, expecting it to hit $160+ in next 5 weeks
Biotech is a stock-picker market and it is easy to pick the wrong stocks. Due to the extreme volatility most biotechs are no buy and hold stocks for me and I trade them more actively than my other positions. HUMA and TMDX (medtech) doubled for me and I sold, others such as TGTX or VRNA I keep. The market wants to see growth and revenue, it is not a time where great stories make biotech stocks soar.
No I don't mind. Some of the stocks are from these list posts and some are from the SqueezeFinder posts where it will have two stocks highlighted. I've made between 10-50% with a total dollar profit of about $6,000 combined on the following stocks: NTCL BKKT TMDX EOSE XAGE I see some others in my trade history that I thought I saw on a SqueezeFinder post but I couldn't find the post. The ones I listed are for sure from SqueezeFinder. As for how I make the choice, I try to buy in when I think the price has been stable-ish for a day or two at least. I don't buy stocks that are already up a bunch or squeezed very recently(within a week or so). Other than that I have a percentage that if it drops I just cut my losses, and I sell...and if it squeezes I sell as soon as it stops riding. I never wait to see if it will go higher. I've missed some bigger gains but I've also timed the exact top on two of these stocks.
Can you please let me know if the TMDX squeeze is expected on July ? I have 160 calls exp. 07/18
TMDX with a 40% increase over the month. You see this squeeze following close Friday?
i posted TMDX here when it was 60 4 months ago and said it would double within a year. It’s 127 now GH will be a $100+ within a year
Both 20 x TMDX 121826 100 C and a similar amount of shares that you have.
GH will be the monopoly of cancer screening 5 years from now. Personal price target 100 My last recommendation on a post like this was TMDX when it was 60, said it would double within a year (and it did in 3 months)
Surprised everyone doesn’t run a train on TMDX shorts a big Eff you to the market while saving lives
Probably should have just grabbed shares and you will see green like TMDX. They are under $300, that’s a chance to nibble. Their options are wonky with big spreads.
Happy to see TMDX continue to grind up today
Nice! TMDX retail holders did a great job on the flight tracking and it paid off for them nicely
Off the top of my head: Probly TMDX in low 60s, OUST in low 6s
That was and still is a great call. TMDX is also one of my holdings. They reported Q1 2025 last week. Their strongest quarter to date. For Q1, revenue of 145 MM was 48% over the previous year and 18% sequentially. Net income was 26 MM. 111% year over year growth. They not only beat on revenue and income for Q1, but also raised their revenue guidance for 2025, which resulted in forecasted growth of 28-30%. This company's is firing on all cylinders and saving lives in the process. Currently up \~20% after this great quarter at 111.73, but it is easily a $150 stock in the near term.